← FDA Drug Approvals (Drugs@FDA)

DARIFENACIN HYDROBROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2016-09-01

Drug application

FDA Application #

ANDA207664

Application type

Abbreviated New Drug Application (Generic)

Brand name

DARIFENACIN HYDROBROMIDE

Generic name

DARIFENACIN HYDROBROMIDE

Active ingredients

DARIFENACIN HYDROBROMIDE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2016-09-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown